Automatized FACEmemory® scoring is related to Alzheimer's disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort.
Alegret M, Sotolongo-Grau O, de Antonio EE, Pérez-Cordón A, Orellana A, Espinosa A, Gil S, Jiménez D, Ortega G, Sanabria A, Roberto N, Hernández I, Rosende-Roca M, Tartari JP, Alarcon-Martin E, de Rojas I, Montrreal L, Morató X, Cano A, Rentz DM, Tárraga L, Ruiz A, Valero S, Marquié M, Boada M.
Alegret M, et al. Among authors: morato x.
Alzheimers Res Ther. 2022 Mar 18;14(1):43. doi: 10.1186/s13195-022-00988-8.
Alzheimers Res Ther. 2022.
PMID: 35303916
Free PMC article.